Pregabalin Capsule
Product Images NDC 50090-7983

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 50090-7983). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907983)

This is a product label for PREGABALTN 260 MG capsules with a pack size of 60 capsules. The product code is 196, 20990-708.*

FDA Label Image

Pregabalinfigure1 (Pregabalinfigure1)

FDA Label Image

Pregabalinfigure10 (Pregabalinfigure10)

FDA Label Image

Pregabalinfigure11 (Pregabalinfigure11)

This text appears to show a table or graph displaying the percentage of subjects improved over time in a program. It includes data points at 100, 210, and 290, possibly referring to different stages or time points. The text also mentions "Percent Improved from Baseline to Week 12," suggesting a comparison over a 12-week period. Additional information suggests that the subjects' progress is being tracked and evaluated.*

FDA Label Image

Pregabalinfigure12 (Pregabalinfigure12)

This text provides data on the percentage of subjects who showed improvement from baseline to week 16 using the BOCF method. The numbers indicate the percentage of subjects who demonstrated improvement at different intervals.*

FDA Label Image

Pregabalinfigure2 (Pregabalinfigure2)

This text provides information about the percentage of patients improved after taking Pragabalin 106 mg three times a day. It also mentions the levels of pain improvement from baseline.*

FDA Label Image

Pregabalinfigure3 (Pregabalinfigure3)

This text provides information about the percentage of patients improved with different doses of Pregabalin and placebo based on the frequency of intake per day. It also indicates the percentage improvement in pain from baseline for each treatment option.*

FDA Label Image

Pregabalinfigure4 (Pregabalinfigure4)

This description provides information on the percentage of patients who improved using Pregabalin at different dosages compared to a placebo. The data shows the percentage improvement in pain from the baseline for each treatment group. The effectiveness of Pregabalin at 200 mg three times a day and 100 mg three times a day is compared with a placebo.*

FDA Label Image

Pregabalinfigure5 (Pregabalinfigure5)

Percentage of Patients Improved is being measured for different treatments: Pregabalin 100mg X 3 times a day, Pregabalin 60mg X 3 times a day, and Placebo. The chart displays the percent improvement in pain from baseline for each treatment group.*

FDA Label Image

Pregabalinfigure6 (Pregabalinfigure6)

FDA Label Image

Pregabalinfigure7 (Pregabalinfigure7)

FDA Label Image

Pregabalinfigure8 (Pregabalinfigure8)

FDA Label Image

Pregabalinfigure9 (Pregabalinfigure9)

FDA Label Image

Pregabalinstructure (Pregabalinstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.